Rare non-synonymous germline mutations systematically define the risk of triple negative breast cancer
M. Yang, F. Y. Fan, Z.-Y. Wu, Z. Feng, Q. Zhang, S. Han, X. Li, T. Zhu, M. Cheng, J. Xu, C. Yang, H. Gao, C. Zhang, G. Tan, M. Q. Zhang, , K. Wang
This paper identifies rare germline mutations associated with triple-negative breast cancer risk using a machine learning approach and shows improved risk prediction compared to existing methods.
bioRxiv · Feb 26, 2019 · PreprintCancer Biology